Skip to main content

MYCN proto-oncogene, bHLH transcription factor

The MYCN gene provides instructions for making a protein that plays an important role in the formation of tissues and organs during development before birth. Studies in animals suggest that this protein is necessary for normal development of the limbs, heart, kidneys, lungs, nervous system, and digestive system. The MYCN protein regulates the activity of other genes by attaching (binding) to specific regions of DNA and controlling the first step of protein production (transcription). On the basis of this action, this protein is called a transcription factor.

Video picks for Genes
Video library

Normal function

The MYCN gene provides instructions for making a protein that plays an important role in the formation of tissues and organs during development before birth. Studies in animals suggest that this protein is necessary for normal development of the limbs, heart, kidneys, lungs, nervous system, and digestive system. The MYCN protein regulates the activity of other genes by attaching (binding) to specific regions of DNA and controlling the first step of protein production (transcription). On the basis of this action, this protein is called a transcription factor.

The MYCN gene belongs to a class of genes known as oncogenes. When mutated, oncogenes have the potential to cause normal cells to become cancerous. The MYCN gene is a member of the Myc family of oncogenes. These genes play important roles in regulating cell growth and division (proliferation) and the self-destruction of cells (apoptosis).

Conditions referring to this gene or chromosome

Other names

bHLHe37

MYCN_HUMAN

MYCNOT

N-myc

N-myc proto-oncogene protein

neuroblastoma MYC oncogene

neuroblastoma-derived v-myc avian myelocytomatosis viral related oncogene

NMYC

oncogene NMYC

pp65/67

v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog

v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived

v-myc myelocytomatosis viral related oncogene, neuroblastoma derived

v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)

Patient picks for Genes

Related patient information and medicines

Acute lymphoblastic leukaemia

Patient information leaflet

Acute lymphoblastic leukaemia

There are various subtypes of ALL. A new therapy that involves modifying a person's own immunce cells to fight the cancer has been recommended by NICE and will be available through the Cance... Kymriah, which is given as a single intravenous infusion, is a pioneering CART-cell treatment that has the potential to be a cure for people under the age.

Neuroblastoma

Patient information leaflet

Neuroblastoma

Neuroblastoma is a cancer affecting developing nerve cells. Neuroblastoma is a rare cancer and most often occurs in children under 5 years old. Neuroblastoma often starts in the tummy (abdomen) but can spread to other parts of the body, especially bones, liver and skin. The treatments for neuroblastoma include surgery... Genetic changes. Some.

Causes of cancer

Patient information leaflet

Causes of cancer

Certain risk factors are known to increase the chance that one or more of your cells will become abnormal and lead to cancer. How does cancer start. The body is made up from millions of tiny cells. Different parts of the body such as organs, bones, muscles, skin and blood are made up from different specialised cells. Most cells have a centre.

Mouth cancer

Patient information leaflet

Mouth cancer

Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if you have a lesion in your mouth (such as a sore, an ulcer or a lump) which has not healed for 3 wee... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or.

Throat cancer

Patient information leaflet

Throat cancer

(The throat is usually sprayed with a local anaesthetic before use of a nasal endoscope, so that the procedure i... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their.

Blood clotting tests

Patient information leaflet

Blood clotting tests

Blood clotting tests are used to diagnose and assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. You may be advised to have blood clotting tests: If you have a suspected bleeding disorder. For example, if you bleed a lot after cuts, or if you bruise easily. If you have certain liver diseases that can.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 18 Aug 2020 | Latest version
  • 1 Jun 2018 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.